Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtomes), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal)), End User (Hospital, Lab) - Global Forecast to 2024
[194 Pages Report] The anatomic pathology market is estimated to grow from USD 33.0 billion in 2019 to USD 44.4 billion by 2024, at a CAGR of 6.1%. The growth in this market is majorly driven by the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper market growth to a certain extent during the forecast period.
Services segment to witness the highest growth during the forecast period
By product & service, the market is segmented into services, instruments, and consumables. The services segment accounted for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.
Disease diagnosis segment accounted for the largest share of the anatomic pathology market, by application, in 2018
Based on application, the market is segmented into disease diagnosis and medical research. The market for disease diagnosis is further segmented into cancer and other diseases. In 2018, the disease diagnosis segment accounted for the largest market share. This can be attributed to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.
North America is the largest regional market for anatomic pathology
Based on region, the market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest market share, followed by Europe. The easy accessibility to advanced technologies, government initiatives for screening cancer patients, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are the major factors driving the growth of the market in North America.
Key Market Players
Prominent players in the anatomic pathology market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Thermo Fisher Scientific (US), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US).
F. Hoffmann-La Roche Ltd. (Switzerland) is the leading player in the market. The company offers a full range of consumables that are used for the diagnosis of various types of diseases, including cancers of the lung, breast, and blood. The company focuses on organic growth strategies to maintain its leading position in the market. For instance, in 2018, the company received CE approval for its BenchMark ULTRA Plus Staining System. Similarly, in April 2017, the company received FDA approval for its CINtec Histology test.
Scope of the Report
|
Report Metric |
Details |
|
Market size available for years |
20172024 |
|
Base year considered |
2018 |
|
Forecast period |
20192024 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Product & service, application, end user, and region |
|
Geographies covered |
North America, Europe, Asia Pacific, and the Rest of the World |
|
Companies covered |
F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Thermo Fisher Scientific (US), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US). |
This report categorizes the market into the following segments and subsegments:
By Product & Service
- Services
- Histopathology
- Cytopathology
- Instruments
- Slide Staining Systems
- Tissue Processing Systems
- Cell Processors
- Microtomes
- Embedded Systems
- Coverslippers
- Other Instruments (Slide Labelers, Grossing Stations, and Paraffin Dispensers)
- Consumables
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Kits & Reagents
- Stains & Solvents
- Fixatives
- Other Kits & Reagents (Blocking Sera, Chromogenic Substrates, Stabilizers, and Diluents)
- Probes
- Other Consumables (Microtome Blades, Slides, Coverslips, and Cassettes)
By Application
- Disease Diagnosis
- Cancer
- Breast Cancer
- Lung Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Other Cancers (Includes Cancers of the Bone, Thyroid, Cervix, Skin, Lymphoma, Gallbladder Carcinoma, Renal Cell Carcinoma, and Pleomorphic Sarcoma)
- Other Diseases (Includes HBV, Epstein-Barr Virus, Liver Diseases, Muscular Dystrophy, and Gastroesophageal Reflux Disease)
- Medical Research
By End User
- Hospital Laboratories
- Clinical Laboratories
- Other End Users
By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- RoE
- Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific
- Rest of the World
- Latin America
- Middle East & Africa
Recent Developments
- In September 2018, Sakura Finetek launched the Accu-Cut SRM 300 LT Manual Microtome.
- In 2018, F. Hoffmann-La Roche received the CE approval for its BenchMark ULTRA Plus Staining System.
- In March 2016, BD received FDA approval for its new automated cervical cancer screening systems, BD Totalys MultiProcessor and BD Totalys SlidePrep instruments
Key Questions Addressed by the Report
- Where will all these developments take the industry in the mid-to-long term?
- What are the recent trends affecting the anatomic pathology market?
- Who are the key players in the market, and how intense is the competition?
- What are the key applications of anatomic pathology instruments and consumables?
- Which region is lucrative for the market?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 21)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 25)
2.1 Research Data
2.2 Secondary Data
2.2.1 Secondary Sources
2.3 Primary Data
2.4 Market Size Estimation
2.4.1 Bottom-Up Approach
2.4.1.1 Bottom-Up Approach for the Instruments and Consumables Market
2.4.2 Top-Down Approach
2.4.2.1 Services Market Estimation Based on Number of Tests
2.4.2.2 Services Market Estimation Based on Procedures
2.4.3 Growth Forecast
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study
3 Executive Summary (Page No. - 33)
3.1 Introduction
4 Premium Insights (Page No. - 37)
4.1 Anatomic Pathology: Market Overview
4.2 North America: Anatomic Pathology Market, By Product & Service
4.3 Geographical Snapshot of the Market
5 Market Overview (Page No. - 40)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Incidence of Cancer and Other Target Diseases
5.2.1.2 Recommendations for Cancer Screening
5.2.1.3 Availability of Reimbursement
5.2.1.4 Growing Focus on Personalized Medicine
5.2.2 Opportunities
5.2.2.1 Emerging Economies
5.2.3 Challenges
5.2.3.1 Availability of Refurbished Products
5.2.3.2 Lack of Skilled Professionals
5.2.3.3 Product Failures and Recalls
5.2.4 Trends
5.2.4.1 Reagent Rental Agreements
6 Anatomic Pathology Market, By Product & Service (Page No. - 45)
6.1 Introduction
6.2 Services
6.2.1 Histopathology
6.2.1.1 the Majority of Cancers are Diagnosed Via HistopathologyA Key Factor Driving Market Growth
6.2.2 Cytopathology
6.2.2.1 Government Focus on Cervical Cancer Screening has Boosted the Growth of the Cytopathology Services Market
6.3 Consumables
6.3.1 Antibodies
6.3.1.1 Primary Antibodies
6.3.1.1.1 North America Dominates the Primary Antibodies Market
6.3.1.2 Secondary Antibodies
6.3.1.2.1 Asia Pacific Will Show the Highest Growth in the Market for Secondary Antibodies
6.3.2 Kits & Reagents
6.3.2.1 Stains & Solvents
6.3.2.1.1 North America Accounted for Highest Share in This Market
6.3.2.2 Fixatives
6.3.2.2.1 North America Accounts for the Largest Share of the Fixatives Market
6.3.2.3 Other Kits & Reagents
6.3.3 Probes
6.3.3.1 APAC is Expected to Show the Highest Growth in the Probes Market
6.3.4 Other Consumables
6.4 Instruments
6.4.1 Slide Staining Systems
6.4.1.1 Availability of Automated Systems Will Drive Market Growth During the Forecast Period
6.4.2 Tissue Processing Systems
6.4.2.1 Rising Adoption of Automation is a Key Trend in the Tissue Processing Systems Market
6.4.3 Cell Processors
6.4.3.1 Cell Processors are Used to Remove Unwanted Matter in SamplesMaking Them Important Instruments in the Market
6.4.4 Microtomes
6.4.4.1 North America Accounts for the Largest Share of the Microtomes Market
6.4.5 Embedding Systems
6.4.5.1 Asia Pacific is Expected to Register the Highest Growth During the Forecast Period
6.4.6 Coverslippers
6.4.6.1 Coverslippers are Widely Used Instruments in Research Alongside Staining Systems
6.4.7 Other Instruments
7 Anatomic Pathology Market, By Application (Page No. - 60)
7.1 Introduction
7.2 Disease Diagnostics
7.2.1 Cancer
7.2.1.1 Breast Cancer
7.2.1.1.1 Breast Cancer Holds the Highest Mortality Rate Among Cancers in North America
7.2.1.2 Gastrointestinal Cancer
7.2.1.2.1 North America Accounts for the Largest Share of the Market for Gastrointestinal Cancer
7.2.1.3 Lung Cancer
7.2.1.3.1 Lung Cancer is the Most Common Cancer in the World
7.2.1.4 Prostate Cancer
7.2.1.4.1 Prostate is the Third-Leading Cause of Death By Cancer in North America
7.2.1.5 Other Cancers
7.2.2 Other Diseases
7.3 Medical Research
7.3.1 Growing Research Activities Will Drive the Adoption of Anatomic Pathology Products in This Application Segment
8 Anatomic Pathology Market, By End User (Page No. - 69)
8.1 Introduction
8.2 Hospital Laboratories
8.2.1 Hospital Laboratories Accounted for the Largest Share of the Market
8.3 Clinical Laboratories
8.3.1 Increasing Outpatient Surgeries to Drive the Growth of This Segment
8.4 Other End Users
9 Anatomic Pathology Market, By Region (Page No. - 74)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominates the Global Market
9.2.2 Canada
9.2.2.1 High Burden of Cancer to Support Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Availability of Reimbursement for Colorectal Cancer Screening to Support Market Growth
9.3.2 France
9.3.2.1 Government Funding for Cancer Diagnosis & Prevention to Support Market Growth
9.3.3 UK
9.3.3.1 Government Initiatives to Drive Market Growth in the UK
9.3.4 Italy
9.3.4.1 High Incidence of Cancer and Increasing Per Capita Healthcare Spending to Support Market Growth in Italy
9.3.5 Spain
9.3.5.1 High Incidence of Chronic Diseases to Drive the Spanish Market
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Presence of a Well-Developed Healthcare System to Support Market Growth in Japan
9.4.2 China
9.4.2.1 Rising Healthcare Expenditure to Drive the Market Growth
9.4.3 India
9.4.3.1 Growing Healthcare Sector in the Country to Drive Market Growth
9.4.4 Rest of Asia Pacific
9.5 Rest of the World
9.5.1 Latin America
9.5.1.1 Cancer Screening Programs to Support Market Growth
9.5.2 Middle East & Africa
9.5.2.1 Increasing Incidence of Cancer in Africa to Support Market Growth
10 Competitive Landscape (Page No. - 143)
10.1 Overview
10.2 Market Share Analysis, 2018
10.3 Competitive Scenario
10.3.1 Agreements & Partnerships (20162019)
10.3.2 Expansions (20162019)
10.3.3 Product Launches & Approvals (20162019)
10.3.4 Acquisitions (20162019)
10.4 Competitive Leadership Mapping (2019)
10.4.1 Vendor Inclusion Criteria
10.4.2 Visionary Leaders
10.4.3 Innovators
10.4.4 Dynamic Differentiators
10.4.5 Emerging Companies
11 Company Profiles (Page No. - 150)
11.1 F. Hoffman-La Roche Ltd.
11.1.1 Business Overview
11.1.2 Products Offered
11.1.3 MnM View
11.2 Danaher
11.2.1 Business Overview
11.2.2 Products Offered
11.2.3 Recent Developments
11.2.4 MnM View
11.3 Thermo Fisher Scientific
11.3.1 Business Overview
11.3.2 Products Offered
11.3.3 Recent Developments
11.3.4 MnM View
11.4 Abcam PLC.
11.4.1 Business Overview
11.4.2 Products Offered
11.4.3 Recent Developments
11.5 Hologic, Inc.
11.5.1 Business Overview
11.5.2 Products Offered
11.5.3 Recent Developments
11.6 Agilent Technologies
11.6.1 Business Overview
11.6.2 Products Offered
11.7 Becton, Dickinson and Company
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Recent Developments
11.7.4 MnM View
11.8 Sakura Finetek USA Inc.
11.8.1 Business Overview
11.8.2 Products Offered
11.8.3 Recent Developments
11.9 Merck KGaA
11.9.1 Business Overview
11.9.2 Products Offered
11.9.3 Recent Developments
11.10 Bio SB
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments
11.11 BioGenex
11.11.1 Business Overview
11.11.2 Products Offered
11.12 Milestone Medical
11.12.1 Business Overview
11.12.2 Products Offered
11.13 Histo-Line Laboratories
11.13.1 Business Overview
11.13.2 Products Offered
11.13.3 Recent Developments
11.14 Diapath S.P.A.
11.14.1 Business Overview
11.14.2 Products Offered
11.14.3 Recent Developments
11.15 Slee Medical GmbH
11.15.1 Business Overview
11.15.2 Products Offered
11.16 Amos Scientific Pty Ltd
11.16.1 Business Overview
11.16.2 Products Offered
11.17 Medite GmbH
11.17.1 Business Overview
11.17.2 Products Offered
11.18 Cell Signaling Technology
11.18.1 Business Overview
11.18.2 Products Offered
11.18.3 Recent Developments
11.19 CeLLPath Ltd.
11.19.1 Business Overview
11.19.2 Products Offered
11.20 Jinhua Yidi Medical Appliance Co. Ltd
11.20.1 Business Overview
11.20.2 Products Offered
12 Appendix (Page No. - 186)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets Subscription Portal
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details
List of Tables (232 Tables)
Table 1 Global Cancer Incidence, 2018 Vs. 2025
Table 2 Growth in the Number of Personalized Medicines, 20082016
Table 3 Number of Pathologists Per 100,000 Population, By Country, 2018
Table 4 Anatomic Pathology Market, By Product & Service, 20172024 (USD Million)
Table 5 Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 6 Histopathology Services Market, By Region, 20172024 (USD Million)
Table 7 Cytopathology Services Market, By Region, 20172024 (USD Million)
Table 8 Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 9 Antibodies Market, By Type, 20172024 (USD Million)
Table 10 Primary Antibodies Market, By Region, 20172024 (USD Million)
Table 11 Secondary Antibodies Market, By Region, 20172024 (USD Million)
Table 12 Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 13 Stains & Solvents Market, By Region, 20172024 (USD Million)
Table 14 Fixatives Market, By Region, 20172024 (USD Million)
Table 15 Other Kits & Reagents Market, By Region, 20172024 (USD Million)
Table 16 Probes Market, By Region, 20172024 (USD Million)
Table 17 Other Consumables Market, By Region, 20172024 (USD Million)
Table 18 Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 19 Slide Staining Systems Market, By Region, 20172024 (USD Million)
Table 20 Tissue Processing Systems Market, By Region, 20172024 (USD Million)
Table 21 Cell Processors Market, By Region, 20172024 (USD Million)
Table 22 Microtomes Market, By Region, 20172024 (USD Million)
Table 23 Embedding Systems Market, By Region, 20172024 (USD Million)
Table 24 Coverslippers Market, By Region, 20172024 (USD Million)
Table 25 Other Instruments Market, By Region, 20172024 (USD Million)
Table 26 Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 27 Market for Disease Diagnostics, By Disease Type, 20172024 (USD Million)
Table 28 Market for Cancer, By Type, 20172024 (USD Million)
Table 29 Breast Cancer Incidence, By Region, 2018 Vs. 2025
Table 30 Market for Breast Cancer, By Region, 20172024 (USD Million)
Table 31 Stomach Cancer Incidence, By Region, 2018 Vs. 2025
Table 32 Market for Gastrointestinal Cancer, By Region, 20172024 (USD Million)
Table 33 Lung Cancer Incidence, By Region, 2018 Vs. 2025
Table 34 Market for Lung Cancer, By Region, 20172024 (USD Million)
Table 35 Prostate Cancer Incidence, By Region, 2018 Vs. 2025
Table 36 Market for Prostate Cancer, By Region, 20172024 (USD Million)
Table 37 Market for Other Cancers, By Region, 20172024 (USD Million)
Table 38 Market for Other Diseases, By Region, 20172024 (USD Million)
Table 39 Market for Medical Research, By Region, 20172024 (USD Million)
Table 40 Market, By End User, 20172024 (USD Million)
Table 41 Market for Hospital Laboratories, By Region, 20172024 (USD Million)
Table 42 Anatomic Pathology Market for Clinical Laboratories, By Region, 20172024 (USD Million)
Table 43 Market for Other End Users, By Region, 20172024 (USD Million)
Table 44 Market, By Region, 20172024 (USD Million)
Table 45 North America: Anatomic Pathology Market, By Country, 20172024 (USD Million)
Table 46 North America: Market, By Product & Service, 20172024 (USD Million)
Table 47 North America: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 48 North America: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 49 North America: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 50 North America: Antibodies Market, By Type, 20172024 (USD Million)
Table 51 North America: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 52 North America: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 53 North America: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 54 North America: Market for Cancer, By Type, 20172024 (USD Million)
Table 55 North America: Market, By End User, 20172024 (USD Million)
Table 56 US: Market, By Product & Service, 20172024 (USD Million)
Table 57 US: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 58 US: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 59 US: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 60 US: Antibodies Market, By Type, 20172024 (USD Million)
Table 61 US: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 62 US: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 63 US: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 64 US: Market for Cancer, By Type, 20172024 (USD Million)
Table 65 US: Market, By End User, 20172024 (USD Million)
Table 66 Canada: Key Macroindicators
Table 67 Canada: Market, By Product & Service, 20172024 (USD Million)
Table 68 Canada: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 69 Canada: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 70 Canada: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 71 Canada: Antibodies Market, By Type, 20172024 (USD Million)
Table 72 Canada: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 73 Canada: Market, By Application, 20172024 (USD Million)
Table 74 Canada: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 75 Canada: Market for Cancer, By Type, 20172024 (USD Million)
Table 76 Canada: Market, By End User, 20172024 (USD Million)
Table 77 Europe: Market, By Country, 20172024 (USD Million)
Table 78 Europe: Market, By Product & Service, 20172024 (USD Million)
Table 79 Europe: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 80 Europe: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 81 Europe: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 82 Europe: Antibodies Market, By Type, 20172024 (USD Million)
Table 83 Europe: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 84 Europe: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 85 Europe: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 86 Europe: Market for Cancer, By Type, 20172024 (USD Million)
Table 87 Europe: Market, By End User, 20172024 (USD Million)
Table 88 Incidence of Cancer, By Type, 2018 Vs. 2025
Table 89 Germany: Market, By Product & Service, 20172024 (USD Million)
Table 90 Germany: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 91 Germany: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 92 Germany: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 93 Germany: Antibodies Market, By Type, 20172024 (USD Million)
Table 94 Germany: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 95 Germany: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 96 Germany: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 97 Germany: Market for Cancer, By Type, 20172024 (USD Million)
Table 98 Germany: Market, By End User, 20172024 (USD Million)
Table 99 Cancer Incidence, By Type, 2018 Vs. 2025
Table 100 France: Market, By Product & Service, 20172024 (USD Million)
Table 101 France: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 102 France: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 103 France: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 104 France: Antibodies Market, By Type, 20172024 (USD Million)
Table 105 France: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 106 France: Market, By Application, 20172024 (USD Million)
Table 107 France: Anatomic Pathology Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 108 France: Market for Cancer, By Type, 20172024 (USD Million)
Table 109 France: Market, By End User, 20172024 (USD Million)
Table 110 UK: Market, By Product & Service, 20172024 (USD Million)
Table 111 UK: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 112 UK: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 113 UK: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 114 UK: Antibodies Market, By Type, 20172024 (USD Million)
Table 115 UK: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 116 UK: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 117 UK: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 118 UK: Market for Cancer, By Type, 20172024 (USD Million)
Table 119 UK: Market, By End User, 20172024 (USD Million)
Table 120 Incidence of Cancer, By Type, 2018 Vs. 2025
Table 121 Italy: Market, By Product & Service, 20172024 (USD Million)
Table 122 Italy: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 123 Italy: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 124 Italy: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 125 Italy: Antibodies Market, By Type, 20172024 (USD Million)
Table 126 Italy: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 127 Italy: Market, By Application, 20172024 (USD Million)
Table 128 Italy: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 129 Italy: Market for Cancer, By Type, 20172024 (USD Million)
Table 130 Italy: Market, By End User, 20172024 (USD Million)
Table 131 Spain: Market, By Product & Service, 20172024 (USD Million)
Table 132 Spain: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 133 Spain: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 134 Spain: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 135 Spain: Antibodies Market, By Type, 20172024 (USD Million)
Table 136 Spain: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 137 Spain: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 138 Spain: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 139 Spain: Market for Cancer, By Type, 20172024 (USD Million)
Table 140 Spain: Market, By End User, 20172024 (USD Million)
Table 141 RoE: Market, By Product & Service, 20172024 (USD Million)
Table 142 RoE: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 143 RoE: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 144 RoE: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 145 RoE: Antibodies Market, By Type, 20172024 (USD Million)
Table 146 RoE: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 147 RoE: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 148 RoE: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 149 RoE: Market for Cancer, By Type, 20172024 (USD Million)
Table 150 RoE: Market, By End User, 20172024 (USD Million)
Table 151 Asia Pacific: Anatomic Pathology Market, By Country, 20172024 (USD Million)
Table 152 Asia Pacific: Market, By Product & Service, 20172024 (USD Million)
Table 153 Asia Pacific: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 154 Asia Pacific: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 155 Asia Pacific: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 156 Asia Pacific: Antibodies Market, By Type 20172024 (USD Million)
Table 157 Asia Pacific: Kits & Reagents Market, By Type 20172024 (USD Million)
Table 158 Asia Pacific: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 159 Asia Pacific: Anatomic Pathology Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 160 Asia Pacific: Market for Cancer, By Type, 20172024 (USD Million)
Table 161 Asia Pacific: Market, By End User, 20172024 (USD Million)
Table 162 Japan: Market, By Product & Service, 20172024 (USD Million)
Table 163 Japan: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 164 Japan: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 165 Japan: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 166 Japan: Antibodies Market, By Type, 20172024 (USD Million)
Table 167 Japan: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 168 Japan: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 169 Japan: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 170 Japan: Market for Cancer, By Type, 20172024 (USD Million)
Table 171 Japan: Market, By End User, 20172024 (USD Million)
Table 172 China: Market, By Product & Service, 20172024 (USD Million)
Table 173 China: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 174 China: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 175 China: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 176 China: Antibodies Market, By Type, 20172024 (USD Million)
Table 177 China: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 178 China: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 179 China: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 180 China: Market for Cancer, By Type, 20172024 (USD Million)
Table 181 China: Market, By End User, 20172024 (USD Million)
Table 182 India: Market, By Product & Service, 20172024 (USD Million)
Table 183 India: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 184 India: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 185 India: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 186 India: Antibodies Market, By Type, 20172024 (USD Million)
Table 187 India: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 188 India: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 189 India: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 190 India: Market for Cancer, By Type, 20172024 (USD Million)
Table 191 India: Market, By End User, 20172024 (USD Million)
Table 192 RoAPAC: Market, By Product & Service, 20172024 (USD Million)
Table 193 RoAPAC: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 194 RoAPAC: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 195 RoAPAC: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 196 RoAPAC: Antibodies Market, By Type, 20172024 (USD Million)
Table 197 RoAPAC: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 198 RoAPAC: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 199 RoAPAC: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 200 RoAPAC: Market for Cancer, By Type, 20172024 (USD Million)
Table 201 RoAPAC: Market, By End User, 20172024 (USD Million)
Table 202 RoW: Market, By Region, 20172024 (USD Million)
Table 203 RoW: Market, By Product & Service, 20172024 (USD Million)
Table 204 RoW: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 205 RoW: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 206 RoW: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 207 RoW: Antibodies Market, By Type, 20172024 (USD Million)
Table 208 RoW: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 209 RoW: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 210 RoW: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 211 RoW: Market for Cancer, By Type, 20172024 (USD Million)
Table 212 RoW: Market, By End User, 20172024 (USD Million)
Table 213 Latin America: Market, By Product & Service, 20172024 (USD Million)
Table 214 Latin America: Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 215 Latin America: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 216 Latin America: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 217 Latin America: Antibodies Market, By Type, 20172024 (USD Million)
Table 218 Latin America: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 219 Latin America: Market, By Application, 20172024 (USD Million)
Table 220 Latin America: Anatomic Pathology Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 221 Latin America: Market for Cancer, By Type, 20172024 (USD Million)
Table 222 Latin America: Market, By End User, 20172024 (USD Million)
Table 223 Middle East & Africa: Market, By Product & Service, 20172024 (USD Million)
Table 224 Middle East & Africa : Anatomic Pathology Services Market, By Type, 20172024 (USD Million)
Table 225 Middle East & Africa: Anatomic Pathology Instruments Market, By Type, 20172024 (USD Million)
Table 226 Middle East & Africa: Anatomic Pathology Consumables Market, By Type, 20172024 (USD Million)
Table 227 Middle East & Africa: Antibodies Market, By Type, 20172024 (USD Million)
Table 228 Middle East & Africa: Kits & Reagents Market, By Type, 20172024 (USD Million)
Table 229 Middle East & Africa: Anatomic Pathology Market, By Application, 20172024 (USD Million)
Table 230 Middle East & Africa: Market for Disease Diagnostics, By Type, 20172024 (USD Million)
Table 231 Middle East & Africa: Market for Cancer, By Type, 20172024 (USD Million)
Table 232 Middle East & Africa: Market, By End User, 20172024 (USD Million)
List of Figures (35 Figures)
Figure 1 Anatomic Pathology Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation: Bottom-Up Approach
Figure 5 Market Size Estimation: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Product & Service, 2019 Vs. 2024 (USD Million)
Figure 8 Anatomic Pathology Instruments Market, By Type, 2019 Vs. 2024 (USD Million)
Figure 9 Anatomic Pathology Consumables Market, By Type, 2019 Vs. 2024 (USD Million)
Figure 10 Anatomic Pathology Market, By Application, 2019 Vs. 2024 (USD Million)
Figure 11 Market, By End User, 2019 Vs. 2024 (USD Million)
Figure 12 Market, By Region, 2019 Vs. 2024 (USD Million)
Figure 13 High Incidence of Cancer & Other Target Diseases to Drive Market Growth
Figure 14 Services Accounted for the Largest Share of the North American Anatomic Pathology Market in 2018
Figure 15 Countries in the Asia Pacific to Register the Highest Growth Rate During the Forecast Period
Figure 16 Market: Drivers, Opportunities, Challenges, and Trends
Figure 17 Services to Continue to Dominate the Market During the Forecast Period
Figure 18 Disease Diagnostics Applications to Continue to Dominate the Market During the Forecast Period
Figure 19 Hospital Laboratories to Dominate the Market During the Forecast Period
Figure 20 North America Will Continue to Dominate the Market in 2024
Figure 21 North America: Market Snapshot
Figure 22 US: Cancer Statistics
Figure 23 Canada: Cancer Statistics
Figure 24 Key Developments in the Market Between 2016 and 2019
Figure 25 Market Evolution Framework
Figure 26 Anatomic Pathology Market Share Analysis, By Instrument and Consumable Provider, 2018
Figure 27 MnM Dive-Vendor Comparison Matrix: Market
Figure 28 Company Snapshot: F. Hoffmann-La Roche (2018)
Figure 29 Company Snapshot: Danaher (2018)
Figure 30 Company Snapshot: Thermo Fisher Scientific (2018)
Figure 31 Company Snapshot: Abcam PLC. (2018)
Figure 32 Company Snapshot: Hologic, Inc. (2018)
Figure 33 Company Snapshot: Agilent Technologies (2018)
Figure 34 Company Snapshot: Becton, Dickinson and Company (2018)
Figure 35 Company Snapshot: Merck KGaA (Life Sciences Segment) (2018)
This study involved four major activities in estimating the current size of the anatomic pathology market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was mainly used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the market. The secondary sources used for this study include the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), American Cancer Society (ACS), Organisation for Economic Co-operation and Development (OECD), European Centre for Disease Prevention and Control (ECDC), National Society for Histotechnology (NSH), Association of Anatomical Pathology Technology, Annual Reports, Press Releases, SEC Filings, and Investor Presentations. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the anatomic pathology market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the market have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, and forecast the anatomic pathology market on the basis of product & service, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, challenges, opportunities, and trends)
- To strategically analyze micromarkets with respect to their individual growth trends, future prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (RoW)
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, new product launches, expansions, agreements, partnerships, collaborations, and R&D activities in the market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for this report:
Country Information
- Anatomic pathology market size and growth rate estimates for counties in Rest of Europe and the Rest of Asia Pacific
Company profiles
- Additional five company profiles of players operating in the market
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Anatomic Pathology Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Anatomic Pathology Market